A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)

BACKGROUND: This multicenter, phase II trial tested the tolerability and efficacy of lenalidomide plus rituximab in patients with previously untreated follicular lymphoma (FL). PATIENTS AND METHODS: Patients with grade 1–3a FL, stage 3–4 or bulky stage 2, FL international prognostic index (FLIPI) 0–...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Oncol
Autors principals: Martin, P, Jung, S -H, Pitcher, B, Bartlett, N L, Blum, K A, Shea, T, Hsi, E D, Ruan, J, Smith, S E, Leonard, J P, Cheson, B D
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5789808/
https://ncbi.nlm.nih.gov/pubmed/28945884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdx496
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars